Karyopharm Therapeutics Inc. - Common Stock — 재무제표 (NASDAQ:KPTI) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 313.05 M305.31 M358.17 M240.44 M164.42 M108.42 M 총 부채 262.5 M384.98 M374.83 M376.64 M350.44 M401.34 M 자본금 총액 50.55 M-79.67 M-16.66 M-136.21 M-186.02 M-292.93 M 총 부채 및 주주자본 313.05 M305.31 M358.17 M240.44 M164.42 M108.42 M 총부채 117.93 M169.29 M170.1 M170.92 M94.6 M115.81 M 순부채 -131.31 M-59.32 M-107.86 M-20.52 M-14.11 M52.1 M

뉴스

Wall Street Analysts Think Karyopharm Therapeutics (KPTI) Could Surge 70.46%: Read This Before Placing a Bet

Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Beats Revenue Estimates

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

Karyopharm: Putting The Phase 3 Trial In Context (NASDAQ:KPTI)

KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data

Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis - Slideshow (NASDAQ:KPTI) 2026-03-25

Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis Transcript

Why Is Karyopharm Therapeutics Stock Trading Lower Today? - Karyopharm Therapeutics (NASDAQ:KPTI)

카리오팜 주식, 로드먼 앤 렌쇼 ’매수’ 등급 개시

Rodman & Renshaw initiates Karyopharm stock with buy rating